Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients.

Tsai EW, Rianthavorn P, Gjertson DW, Wallace WD, Reed EF, Ettenger RB.

Transplantation. 2006 Dec 27;82(12):1769-73.

PMID:
17198274
2.

CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival.

Bagnasco SM, Tsai W, Rahman MH, Kraus ES, Barisoni L, Vega R, Racusen LC, Haas M, Mohammed BS, Zachary AA, Montgomery RA.

Am J Transplant. 2007 Aug;7(8):1968-73.

3.

Significance of intragraft CD138+ lymphocytes and p-S6RP in pediatric kidney transplant biopsies.

Tsai EW, Wallace WD, Gjertson DW, Reed EF, Ettenger RB.

Transplantation. 2010 Oct 27;90(8):875-81. doi: 10.1097/TP.0b013e3181f24e3c.

4.

Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss.

Muorah MR, Brogan PA, Sebire NJ, Trompeter RS, Marks SD.

Pediatr Transplant. 2009 Mar;13(2):217-22. doi: 10.1111/j.1399-3046.2008.00943.x. Epub 2008 Apr 22.

PMID:
18433412
5.

Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.

Martins HL, Silva C, Martini D, Noronha IL.

Transplant Proc. 2007 Mar;39(2):432-4.

PMID:
17362749
6.

Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts.

Hippen BE, DeMattos A, Cook WJ, Kew CE 2nd, Gaston RS.

Am J Transplant. 2005 Sep;5(9):2248-52.

7.

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra O Jr.

N Engl J Med. 2003 Jul 10;349(2):125-38.

8.

Urinary CD20 mRNA as a surrogate of CD20-positive cells infiltration during allograft dysfunction in renal transplant patients.

Ponciano VC, Soares MF, Naka EL, Arruda EF, Cenedeze MA, Franco MF, Pacheco-Silva A, Câmara NO.

Int Immunopharmacol. 2009 Jun;9(6):663-7. doi: 10.1016/j.intimp.2008.11.017. Epub 2008 Dec 25.

PMID:
19111631
9.

Acute rejection and graft survival in renal transplanted patients with viral diseases.

Aiello FB, Calabrese F, Rigotti P, Furian L, Marino S, Cusinato R, Valente M.

Mod Pathol. 2004 Feb;17(2):189-96.

10.

B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.

Scheepstra C, Bemelman FJ, van der Loos C, Rowshani AT, van Donselaar-Van der Pant KA, Idu MM, ten Berge IJ, Florquin S.

Transplantation. 2008 Sep 27;86(6):772-8. doi: 10.1097/TP.0b013e3181860a74.

PMID:
18813100
11.

Expression patterns of B cells in acute kidney transplant rejection.

Carpio VN, Noronha Ide L, Martins HL, Jobim LF, Gil BC, Külzer AS, Loreto Mda S, Gonçalves LF, Manfro RC, Veronese FV.

Exp Clin Transplant. 2014 Oct;12(5):405-14.

12.

Clinical impacts of CD38+ B cells on acute cellular rejection with CD20+ B cells in renal allograft.

Hwang HS, Song JH, Hyoung BJ, Lee SY, Jeon YJ, Kang SH, Chung BH, Choi BS, Choi YJ, Kim JI, Moon IS, Kim YS, Yang CW.

Transplantation. 2010 Jun 27;89(12):1489-95. doi: 10.1097/TP.0b013e3181dd35b8.

PMID:
20393401
13.

A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.

Zarkhin V, Li L, Kambham N, Sigdel T, Salvatierra O, Sarwal MM.

Am J Transplant. 2008 Dec;8(12):2607-17. doi: 10.1111/j.1600-6143.2008.02411.x. Epub 2008 Sep 18.

14.

Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.

Alausa M, Almagro U, Siddiqi N, Zuiderweg R, Medipalli R, Hariharan S.

Clin Transplant. 2005 Feb;19(1):137-40.

PMID:
15659147
15.

The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft.

Doria C, di Francesco F, Ramirez CB, Frank A, Iaria M, Francos G, Marino IR, Farber JL.

Transplant Proc. 2006 Dec;38(10):3441-4.

PMID:
17175297
16.
17.

C4d in pediatric renal allograft biopsies: a marker for negative outcome in steroid-resistant rejection.

Vargha R, Mueller T, Arbeiter K, Regele H, Exner M, Csaicsich D, Aufricht C.

Pediatr Transplant. 2006 Jun;10(4):449-53.

PMID:
16712602
18.

Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection.

Krukemeyer MG, Moeller J, Morawietz L, Rudolph B, Neumann U, Theruvath T, Neuhaus P, Krenn V.

Transplantation. 2004 Jul 15;78(1):65-70.

PMID:
15257040
19.

The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy.

Haririan A, Kiangkitiwan B, Kukuruga D, Cooper M, Hurley H, Drachenberg C, Klassen D.

Am J Transplant. 2009 Dec;9(12):2758-67. doi: 10.1111/j.1600-6143.2009.02836.x. Epub 2009 Oct 21.

20.

Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.

Everly MJ, Everly JJ, Arend LJ, Brailey P, Susskind B, Govil A, Rike A, Roy-Chaudhury P, Mogilishetty G, Alloway RR, Tevar A, Woodle ES.

Am J Transplant. 2009 May;9(5):1063-71. doi: 10.1111/j.1600-6143.2009.02577.x. Epub 2009 Mar 16.

Items per page

Supplemental Content

Write to the Help Desk